{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:32:21Z","timestamp":1740148341806,"version":"3.37.3"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019582","name":"The Larry and Helen Hoag Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.scr.2024.103552","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T21:51:09Z","timestamp":1725745869000},"page":"103552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Generation of an infantile GM1 gangliosidosis induced pluripotent stem cell line (CHOCi005-A) for disease modeling and therapeutic testing"],"prefix":"10.1016","volume":"81","author":[{"given":"Allisandra K.","family":"Rha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe L.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Hsin","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry F.","family":"Harb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perla","family":"Andrade-Heckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.scr.2024.103552_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/TACG.S206076","article-title":"GM1 Gangliosidosis: Mechanisms and Management","volume":"14","author":"Ak","year":"2021","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.scr.2024.103552_b0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ymgme.2008.04.012","article-title":"GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects","volume":"94","author":"Brunetti-Pierri","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.scr.2024.103552_b0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/humu.20147","article-title":"Role of \u03b2-galactosidase and elastin binding protein in lysosomal and nonlysosomal complexes of patients with GM1-gangliosidosis","volume":"25","author":"Caciotti","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.scr.2024.103552_b0020","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbadis.2011.03.018","article-title":"GM1 gangliosidosis and Morquio B disease: An update on genetic alterations and clinical findings","volume":"1812","author":"Caciotti","year":"2011","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.scr.2024.103552_b0025","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s11011-017-0044-y","article-title":"The treatment of juvenile\/adult GM1-gangliosidosis with Miglustat may reverse disease progression","volume":"32","author":"Deodato","year":"2017","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.scr.2024.103552_b0030","first-page":"465","article-title":"Chronic GM1 gangliosidosis presenting as dystonia: I","volume":"9","author":"Goldman","year":"1981","journal-title":"Clinical and Pathological Features. Ann Neurol"},{"key":"10.1016\/j.scr.2024.103552_b0035","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ymthe.2017.01.009","article-title":"Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline Model","volume":"25","author":"Gray-Edwards","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.scr.2024.103552_b0040","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/humu.21516","article-title":"Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in \u03b2-galactosidase deficiency","volume":"32","author":"Higaki","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.scr.2024.103552_b0045","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/humu.21031","article-title":"GM1 gangliosidosis and Morquio B disease: Expression analysis of missense mutations affecting the catalytic site of acid \u03b2-galactosidase","volume":"30","author":"Hofer","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.scr.2024.103552_b0050","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bbrc.2015.01.023","article-title":"Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders","volume":"457","author":"Kwak","year":"2015","journal-title":"Biochem. Biophys Res Commun"},{"key":"10.1016\/j.scr.2024.103552_b0055","article-title":"Human GLB1 knockout cerebral organoids: A model system for testing AAV9-mediated GLB1 gene therapy for reducing GM1 ganglioside storage in GM1 gangliosidosis","volume":"21","author":"Latour","year":"2019","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.scr.2024.103552_b0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/A:1018573518127","article-title":"Beta-galactosidase-deficient mouse as an animal model for GM1-gangliosidosis","volume":"14","author":"Matsuda","year":"1997","journal-title":"Glycoconj J"},{"key":"10.1016\/j.scr.2024.103552_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.734878","article-title":"GM1 Gangliosidosis\u2014A Mini-Review","volume":"12","author":"Nicoli","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.scr.2024.103552_b0070","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1074\/jbc.M111.293795","article-title":"Crystal structure of human \u03b2-galactosidase: Structural basis of GM1 gangliosidosis and morquio B diseases","volume":"287","author":"Ohto","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.scr.2024.103552_b0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ymgme.2018.11.002","article-title":"Comprehensive behavioral and biochemical outcomes of novel murine models of GM1-gangliosidosis and Morquio syndrome type B","volume":"126","author":"Przybilla","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.scr.2024.103552_b0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-3476(85)80472-8","article-title":"Cardiac involvement in diseases characterized by \u03b2-galactosidase deficiency","volume":"106","author":"Rosenberg","year":"1985","journal-title":"J Pediatr"},{"key":"10.1016\/j.scr.2024.103552_b0085","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.3390\/cells11162579","article-title":"Preclinical Enzyme Replacement Therapy with a Recombinant \u03b2-Galactosidase-Lectin Fusion for CNS Delivery and Treatment of GM1-Gangliosidosis","volume":"11","author":"Weesner","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.scr.2024.103552_b0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ana.410310316","article-title":"GM1 gangliosidosis in adults: Clinical and molecular analysis of 16 Japanese patients","volume":"31","author":"Yoshida","year":"1992","journal-title":"Ann Neurol"}],"container-title":["Stem Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506124002502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506124002502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T17:41:40Z","timestamp":1739814100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1873506124002502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":18,"alternative-id":["S1873506124002502"],"URL":"https:\/\/doi.org\/10.1016\/j.scr.2024.103552","relation":{},"ISSN":["1873-5061"],"issn-type":[{"type":"print","value":"1873-5061"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of an infantile GM1 gangliosidosis induced pluripotent stem cell line (CHOCi005-A) for disease modeling and therapeutic testing","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scr.2024.103552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103552"}}